Related Experiment Video
Updated: Sep 18, 2025

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
Published on: June 20, 2017
Expression and function of β-site amyloid precursor protein-cleaving enzyme 2 in vascular endothelium
Livius V d'Uscio1,2, Tetiana Kovalenko3, Tongrong He1,2
1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.
Abstract:
The physiological function of β-site amyloid precursor protein-cleaving enzyme 2 (BACE2) in vascular endothelium of systemic arteries is unknown. In the present study, we generated conditional tamoxifen-inducible endothelial BACE2-deficient mice (eBACE2-/- mice). Electron microscopic and Western blot analyses revealed that BACE2 protein is mainly present in endothelial cells of aorta. Genetic deletion of BACE2 in endothelial cells significantly impaired endothelium-dependent relaxations to Ca2+-ionophore A23187 in eBACE2-/- aortas as compared with tamoxifen-treated control mice, irrespective of sex. Blockade of nitric oxide synthase (NOS) with Nω-nitro-l-arginine methyl ester abolished relaxations to A23187. In contrast, endothelium-independent relaxations to nitric oxide donor diethylamine-NONOate were unchanged. Expression of endothelial NOS protein and levels of cyclic nucleotides were also unaffected in eBACE2-/- mice. Further analysis of the mechanisms underlying impaired endothelial function demonstrated that treatment with thromboxane A2 receptor antagonist SQ29548 ameliorated relaxations to A23187 in the aorta of male and female eBACE2-/- mice. Furthermore, mRNA and protein expressions of cyclooxygenase-2 as well as production of thromboxane A2 and prostaglandin F2α were significantly increased in the aorta of eBACE2-/- mice. In contrast, production of 6-keto prostaglandin F1α and prostaglandin E2 was not affected. In addition, ex vivo treatment of wild-type aortas with proinflammatory cytokines decreased protein expression of BACE2. The results of our study suggest that increased production of vasoconstrictor prostanoids is responsible for impairment of endothelium-dependent relaxations to A23187 in the aorta of eBACE2-/- mice. We report a previously unrecognized role of BACE2 in the control of endothelial arachidonic acid metabolism and vasomotor function.NEW & NOTEWORTHY The exact physiological role of BACE2 in endothelial function of systemic arteries is unknown. Our study shows that thromboxane A2 and prostaglandin F2α are responsible for impairment of endothelium-dependent relaxations in endothelium-specific BACE2-deficient mice. The data support an important role of BACE2 in the control of endothelial arachidonic acid metabolism and vasomotor function.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Caspases
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Clot Retraction and Fibrinolysis
Leaky Scanning
Coronary Artery Disease II: Pathophysiology

